» Articles » PMID: 24278321

Stem Cell Antigen 1-positive Mesenchymal Cells Are the Origin of Follicular Cells During Thyroid Regeneration

Overview
Journal PLoS One
Date 2013 Nov 27
PMID 24278321
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Many tissues are thought to contain adult stem/progenitor cells that are responsible for repair of the tissue where they reside upon damage and/or carcinogenesis, conditions when cellular homeostasis becomes uncontrolled. While the presence of stem/progenitor cells of the thyroid has been suggested, how these cells contribute to thyroid regeneration remains unclear. Here we show the origin of thyroid follicular cells and the process of their maturation to become follicular cells during regeneration. By using β-galactosidase (β-gal) reporter mice in conjunction with partial thyroidectomy as a model for thyroid regeneration, and bromodeoxyuridine (BrdU) long label-retaining cell analysis, we demonstrated that stem cell antigen 1 (Sca1) and BrdU-positive, but β-gal and NKX2-1 negative cells were found in the non-follicular mesenchymal area 7 days after partial thyroidectomy. They temporarily co-expressed cytokeratin 14, and were observed in part of follicles by day 35 post-partial thyroidectomy. Sca1, BrdU, β-gal, and NKX2-1-positive cells were found 120 days post-partial thyroidectomy. These results suggested that Sca1 and BrdU positive cells may participate in the formation of new thyroid follicles after partial thyroidectomy. The process of thyroid follicular cell regeneration was recapitulated in ex vivo thyroid slice collagen gel culture studies. These studies will facilitate research on thyroid stem/progenitor cells and their roles in thyroid diseases, particularly thyroid carcinomas.

Citing Articles

Progress Toward and Challenges Remaining for Thyroid Tissue Regeneration.

Romitti M, Costagliola S Endocrinology. 2023; 164(10).

PMID: 37690118 PMC: 10516459. DOI: 10.1210/endocr/bqad136.


Engineering a functional thyroid as a potential therapeutic substitute for hypothyroidism treatment: A systematic review.

Li L, Sheng Q, Zeng H, Li W, Wang Q, Ma G Front Endocrinol (Lausanne). 2022; 13:1065410.

PMID: 36531472 PMC: 9755335. DOI: 10.3389/fendo.2022.1065410.


Stem Cell Therapy for Thyroid Diseases: Progress and Challenges.

Ye S, Zhu Z Curr Ther Res Clin Exp. 2022; 96:100665.

PMID: 35371349 PMC: 8968462. DOI: 10.1016/j.curtheres.2022.100665.


Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves' hyperthyroidism.

van der Vaart J, Bosmans L, Sijbesma S, Knoops K, van de Wetering W, Otten H Proc Natl Acad Sci U S A. 2021; 118(51).

PMID: 34916298 PMC: 8713972. DOI: 10.1073/pnas.2117017118.


The Transient Human Thyroid Progenitor Cell: Examining the Thyroid Continuum from Stem Cell to Follicular Cell.

Davies T, Latif R, Sachidanandam R, Ma R Thyroid. 2021; 31(8):1151-1159.

PMID: 33678005 PMC: 8377509. DOI: 10.1089/thy.2020.0930.


References
1.
Shimura H, Okajima F, Ikuyama S, Shimura Y, Kimura S, Saji M . Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. Mol Endocrinol. 1994; 8(8):1049-69. DOI: 10.1210/mend.8.8.7997232. View

2.
Radisky D, LaBarge M . Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell. 2008; 2(6):511-2. DOI: 10.1016/j.stem.2008.05.007. View

3.
Burger P, Xiong X, Coetzee S, Salm S, Moscatelli D, Goto K . Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A. 2005; 102(20):7180-5. PMC: 1129148. DOI: 10.1073/pnas.0502761102. View

4.
Osawa M, Hanada K, Hamada H, Nakauchi H . Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996; 273(5272):242-5. DOI: 10.1126/science.273.5272.242. View

5.
Williams E, Toyn C, Harach H . The ultimobranchial gland and congenital thyroid abnormalities in man. J Pathol. 1989; 159(2):135-41. DOI: 10.1002/path.1711590208. View